MLH1, MSH2, PMS2 and EPCAM expressions were correlated to TSPAN4 expression in PRAD, while only EPCAM expression was correlated to TSPAN4 expression in THYM and GBM. This evidence concerns the gene MSH2 and prostate adenocarcinoma.